TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 27189899

Group type: EXPERIMENTAL
Intervention: Educational programme with telephone reinforcement
Number of subjects: 108

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 108
Study: 24454875

Group type: EXPERIMENTAL
Intervention: Government of Kenya's Cash Transfer for Orphans and Vulnerable Children (Kenya CT‐OVC) - unconditional transfer of US$20 per month to the main caregiver
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (households not receiving the cash transfer)
Number of subjects: 14
Study: 22519919

Group type: EXPERIMENTAL
Intervention: Imeglimin 2000 mg once daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Imeglimin 1000 mg twice daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Imeglimin 500 mg twice daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Imeglimin 1500 mg twice daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Metformin 850 mg twice daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 20715737

Group type: EXPERIMENTAL
Intervention: Sevoflurane plus remifentanil (1 microg/kg/minute intraoperatively)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sevoflurane alone
Number of subjects: 60
Study: 18294330

Group type: EXPERIMENTAL
Intervention: Itraconazole 200 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 15842055

Group type: EXPERIMENTAL
Intervention: TIS-assisted screening
Number of subjects: 10742
Study: 12537186

Group type: EXPERIMENTAL
Intervention: Bovine heparin
Number of subjects: 207

Group type: COMPARATOR
Intervention: Porcine heparin
Number of subjects: 207
Study: 10619726

Group type: EXPERIMENTAL
Intervention: No specific therapy for funguria
Number of subjects: 861

Group type: EXPERIMENTAL
Intervention: Catheter removal as the only treatment
Number of subjects: 861

Group type: EXPERIMENTAL
Intervention: Antifungal therapy
Number of subjects: 861

Group type: COMPARATOR
Intervention: Fluconazole
Number of subjects: 861

Group type: COMPARATOR
Intervention: Amphotericin B bladder irrigation
Number of subjects: 861

Group type: COMPARATOR
Intervention: Overall mortality rate
Number of subjects: 861
Study: 8860389

Group type: EXPERIMENTAL
Intervention: Nasal beclomethasone for 8 weeks
Number of subjects: 31

Group type: COMPARATOR
Intervention: Nasal cytology during winter
Number of subjects: 31

Group type: COMPARATOR
Intervention: Nasal cytology during spring
Number of subjects: 31

Group type: COMPARATOR
Intervention: Pathogenic organisms isolated
Number of subjects: 31

Group type: COMPARATOR
Intervention: Atopy prevalence
Number of subjects: 31
Study: 1300186

Group type: EXPERIMENTAL
Intervention: Early surgical treatment of contractures (release of hip flexors, removal of iliotibial bands, lengthening of tendo Achilles bilaterally)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 20
Study: 30589829

Group type: COMPARATOR
Intervention: Supervised progressive resistance training (RT1)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Home-based resistance training (RT2)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Usual care control group (CON)
Number of subjects: 65
Study: 29096686

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation for deficiency prior to THR/TKR for 6 months
Number of subjects: 100

Group type: COMPARATOR
Intervention: No supplementation for patients with normal vitamin D levels (≥50 nmol/L)
Number of subjects: 100
Study: 26458936

Group type: EXPERIMENTAL
Intervention: Respiratory training (RT) for COPD patients, delivered by a physiotherapist for a minimum of 1 hour per visit, with exercises performed at home at least 5 days per week for 12 months.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine health education provided by physiotherapists to the control group over the same period.
Number of subjects: 60
Study: 23567348

Group type: EXPERIMENTAL
Intervention: Sutured transoral outlet reduction (TORe)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Sham procedure (control)
Number of subjects: 77
Study: 20666879

Group type: EXPERIMENTAL
Intervention: SA+CDP
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: all‐TRA+CDP
Number of subjects: 46
Study: 19735404

Group type: EXPERIMENTAL
Intervention: i-gel
Number of subjects: 80

Group type: COMPARATOR
Intervention: LMA-Unique
Number of subjects: 80
Study: 18825439

Group type: EXPERIMENTAL
Intervention: Donepezil or Vitamin E (exact dosage and duration not specified)
Number of subjects: 152
Study: 15830732

Group type: EXPERIMENTAL
Intervention: Gradual withdrawal treatment approaches
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Cluster B personality/borderline personality disorder
Number of subjects: 76

Group type: COMPARATOR
Intervention: Alcohol use-related disorders or other psychiatric diagnoses
Number of subjects: 76
Study: 12477583

Group type: EXPERIMENTAL
Intervention: Remifentanil (n = 1,229) 0.5 microg/kg/min for induction and tracheal intubation followed by an infusion rate of 0.25 microg/kg/min
Number of subjects: 2438

Group type: COMPARATOR
Intervention: Fentanyl (n = 1,209) administered according to the anesthesiologist's usual practice
Number of subjects: 2438
Study: 10512410

Group type: EXPERIMENTAL
Intervention: Preterm formula with arachidonic and docosahexaenoic acid
Number of subjects: 0

Group type: COMPARATOR
Intervention: Preterm formula without arachidonic and docosahexaenoic acid
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Human breast milk
Number of subjects: 0
Study: 7551961

Group type: EXPERIMENTAL
Intervention: Etoposide phosphate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Etoposide
Number of subjects: 0
Study: 1935150

Group type: EXPERIMENTAL
Intervention: Ibuprofen (600 mg iv or 800 mg iv over 20 mins, followed by three 800-mg doses rectally every 6 hrs)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 6750166

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 683

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide
Number of subjects: 683

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (in blacks)
Number of subjects: 683

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (in whites)
Number of subjects: 683
Study: 30948695

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (DEX) administered in the preoperative and intraoperative periods
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 26148587

Group type: EXPERIMENTAL
Intervention: Oxitard capsules (2 capsules twice daily for 3 months)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo (twice daily for 3 months)
Number of subjects: 120
Study: 24463657

Group type: EXPERIMENTAL
Intervention: Robotic sacrocolpopexy
Number of subjects: 78

Group type: COMPARATOR
Intervention: Laparoscopic sacrocolpopexy
Number of subjects: 78
Study: 21295833

Group type: EXPERIMENTAL
Intervention: eLH (equine LH) administered intravenously every 12 h from the day the largest follicle reached 20 mm until a follicle reached >32 mm
Number of subjects: 14

Group type: COMPARATOR
Intervention: Saline (transitional control) administered in the same manner as eLH
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: hCG (3000 IU) administered after a follicle reached >32 mm
Number of subjects: 14

Group type: COMPARATOR
Intervention: Transitional control and transitional eLH groups after hCG-induced ovulation
Number of subjects: 14

Group type: COMPARATOR
Intervention: Circulating estradiol levels
Number of subjects: 14
Study: 19420193

Group type: EXPERIMENTAL
Intervention: 0.2% chlorhexidine
Number of subjects: 512

Group type: COMPARATOR
Intervention: 0.01% potassium permanganate (control)
Number of subjects: 512

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 512
Study: 17665051

Group type: EXPERIMENTAL
Intervention: Valdecoxib (40 mg)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Piroxicam (20 mg)
Number of subjects: 25
Study: 15270931

Group type: EXPERIMENTAL
Intervention: Standard prolonged catheterisation (4 days post-operatively)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Not prolonged catheterisation (removed the morning after surgery)
Number of subjects: 100
Study: 11528363

Group type: EXPERIMENTAL
Intervention: Workbook plus baseline and 6-month surveys
Number of subjects: 580

Group type: EXPERIMENTAL
Intervention: Workbook and 6-month survey
Number of subjects: 580

Group type: EXPERIMENTAL
Intervention: Workbook (combined with surveys)
Number of subjects: 580

Group type: COMPARATOR
Intervention: No workbook with both surveys
Number of subjects: 580
Study: 9749685

Group type: EXPERIMENTAL
Intervention: Macro electromyography (macro EMG)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Electrical stimulation
Number of subjects: 18
Study: 7839259

Group type: EXPERIMENTAL
Intervention: Quinsy tonsillectomy (QT)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Interval tonsillectomy (IT)
Number of subjects: 51
Study: 3049953

Group type: EXPERIMENTAL
Intervention: CNF (cyclophosphamide, mitoxantrone, fluorouracil)
Number of subjects: 331

Group type: COMPARATOR
Intervention: CAF (cyclophosphamide, doxorubicin, fluorouracil)
Number of subjects: 331
Study: 30041167

Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behavioral therapy (ICBT) for 12 weeks
Number of subjects: 100

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 100
Study: 26463567

Group type: COMPARATOR
Intervention: Compression bandaging with NSAIDs (C)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Aspiration (A)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Aspiration with steroid injection (AS)
Number of subjects: 90
Study: 25604722

Group type: EXPERIMENTAL
Intervention: MILK diet (3.2 servings/d of 2% fat milk per 2000 kcal)
Number of subjects: 27

Group type: COMPARATOR
Intervention: NCEP milk-free diet
Number of subjects: 27
Study: 23992241

Group type: EXPERIMENTAL
Intervention: Multidisciplinary depression management program (including activating strategies, psychotherapy, and medication)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Multidisciplinary depression management program
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Activating strategies
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Psychotherapy
Number of subjects: 33

Group type: COMPARATOR
Intervention: Pharmacological depression treatment
Number of subjects: 33
Study: 20577017

Group type: EXPERIMENTAL
Intervention: Plasma exchange (PE)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Standard immunosuppressive therapy (prednisolone and cyclophosphamide)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Change from cyclophosphamide (CYC) to cyclosporine A (CyA)
Number of subjects: 32
Study: 18410941

Group type: EXPERIMENTAL
Intervention: Endocapsule (EC)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Pillcam SB (PSB)
Number of subjects: 51
Study: 17147119

Group type: EXPERIMENTAL
Intervention: Involved-field irradiation (IFI)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Elective node irradiation (ENI)
Number of subjects: 200
Study: 12187444

Group type: EXPERIMENTAL
Intervention: Monitoring condition
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: ABX condition
Number of subjects: 60

Group type: COMPARATOR
Intervention: Free recall condition
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: All conditions
Number of subjects: 60
Study: 10491487

Group type: EXPERIMENTAL
Intervention: Eradication therapy with pantoprazole 40 mg b.i.d., clarithromycin 500 mg b.i.d., and amoxicillin 1 g b.i.d. for 7 or 14 days
Number of subjects: 16
Study: 9005796

Group type: EXPERIMENTAL
Intervention: Ofloxacin administered intravenously during the first days of treatment, followed by oral use
Number of subjects: 15
Study: 1820900

Group type: EXPERIMENTAL
Intervention: Lansoprazole (30 mg) alone
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Lansoprazole with standard meal
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Lansoprazole with antacids (aluminium and magnesium hydroxides)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Lansoprazole administered one hour after antacids
Number of subjects: 12
Study: 7091770

Group type: EXPERIMENTAL
Intervention: Pentaerythritol Tetranitrate (Peritrate) 40 mg chew-and-swallow tablets
Number of subjects: 10
Study: 30082141

Group type: EXPERIMENTAL
Intervention: Citalopram 4 mg (low group)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Citalopram 16 mg (high group)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 26787345

Group type: EXPERIMENTAL
Intervention: Continuous epidural infusion analgesia (ED) with 0.2% Ropivacaine
Number of subjects: 94

Group type: COMPARATOR
Intervention: IV PCA (Fentanyl)
Number of subjects: 94
Study: 25591969

Group type: EXPERIMENTAL
Intervention: Higenamine
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Caffeine
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Higenamine + Caffeine + Yohimbe bark extract
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 23095007

Group type: EXPERIMENTAL
Intervention: estradiol valerate in combination with testosterone undecanoate
Number of subjects: 50

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 50
Study: 19919291

Group type: EXPERIMENTAL
Intervention: Interpersonal counselling (IPC)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Normal care (Control)
Number of subjects: 103
Study: 17440526

Group type: EXPERIMENTAL
Intervention: Glutamine-supplemented HPN (10 g of glutamine)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Standard HPN
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Glutamine-supplemented HPN
Number of subjects: 35
Study: 16620196

Group type: EXPERIMENTAL
Intervention: Transtheoretical Model (TTM) expert system intervention
Number of subjects: 404
Study: 12785564

Group type: EXPERIMENTAL
Intervention: Quality Improvement (QI) interventions
Number of subjects: 1269

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1269
Study: 10722537

Group type: EXPERIMENTAL
Intervention: Transthoracic echocardiography using high frequency (7.5 MHz) transducers
Number of subjects: 60
Study: 9372376

Group type: EXPERIMENTAL
Intervention: Allopurinol
Number of subjects: 24
Study: 8436095

Group type: EXPERIMENTAL
Intervention: Fatty fish consumption
Number of subjects: 28

Group type: COMPARATOR
Intervention: Red meat consumption
Number of subjects: 28
Study: 4027101

Group type: EXPERIMENTAL
Intervention: Subarachnoid anaesthesia (SAB)
Number of subjects: 40

Group type: COMPARATOR
Intervention: General anaesthesia (GA)
Number of subjects: 40
Study: 31884740

Group type: EXPERIMENTAL
Intervention: Beraprost Sodium (BPS)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo (PCB)
Number of subjects: 52
Study: 30400806

Group type: EXPERIMENTAL
Intervention: Written information on a breast milk substitute at discharge (Group A, n=405)
Number of subjects: 802

Group type: COMPARATOR
Intervention: No written information on a breast milk substitute at discharge (Group B, n=397)
Number of subjects: 802

Group type: COMPARATOR
Intervention: Group A vs Group B
Number of subjects: 802
Study: 26509379

Group type: EXPERIMENTAL
Intervention: 10 min of pulsing sinusoidal vibration
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (no vibration)
Number of subjects: 10
Study: 25285531

Group type: EXPERIMENTAL
Intervention: Obatoclax 20 mg/day (3 h × 3 d)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Obatoclax 60 mg/day (24 h × 3 d)
Number of subjects: 12
Study: 22556172

Group type: EXPERIMENTAL
Intervention: Test formulation of omeprazole (OPZ), 40 mg single dose
Number of subjects: 32

Group type: COMPARATOR
Intervention: Reference formulation of omeprazole (OPZ)
Number of subjects: 32
Study: 20053692

Group type: EXPERIMENTAL
Intervention: tenofovir disoproxil fumarate + emtricitabine
Number of subjects: 91

Group type: COMPARATOR
Intervention: Control (baseline antiretroviral regimen)
Number of subjects: 91
Study: 18086590

Group type: EXPERIMENTAL
Intervention: PUVA plus up to 4 UVB 308-nm radiations
Number of subjects: 272

Group type: COMPARATOR
Intervention: PUVA monotherapy
Number of subjects: 272
Study: 15991879

Group type: EXPERIMENTAL
Intervention: Neodolpasse (fixed-dose combination of orphenadrine and diclofenac)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Orphenadrine
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Diclofenac
Number of subjects: 24

Group type: COMPARATOR
Intervention: Saline solution (placebo)
Number of subjects: 24
Study: 12821547

Group type: EXPERIMENTAL
Intervention: Blood cultures positive for Staphylococcus aureus
Number of subjects: 5500

Group type: EXPERIMENTAL
Intervention: Blood cultures positive for other pathogens
Number of subjects: 5500

Group type: EXPERIMENTAL
Intervention: Blood cultures with no growth
Number of subjects: 5500

Group type: EXPERIMENTAL
Intervention: No blood cultures obtained
Number of subjects: 5500

Group type: COMPARATOR
Intervention: Negative blood cultures
Number of subjects: 5500
Study: 10842278

Group type: EXPERIMENTAL
Intervention: Concentric isokinetic leg extension training (6 sets, 3 days/week for 12 weeks at 90 degrees/s)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 21
Study: 9016417

Group type: EXPERIMENTAL
Intervention: Warfarin prescribed
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Warfarin judged appropriate
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Warfarin prescribed to older patients
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Odds ratio for older patients
Number of subjects: 189
Study: 1352024

Group type: EXPERIMENTAL
Intervention: Ondansetron 0.15 mg/kg + dexamethasone 20 mg
Number of subjects: 267

Group type: COMPARATOR
Intervention: Metoclopramide 3 mg/kg + dexamethasone + diphenhydramine 50 mg
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: Ondansetron + dexamethasone
Number of subjects: 267

Group type: COMPARATOR
Intervention: Metoclopramide + dexamethasone + diphenhydramine
Number of subjects: 267
Study: 3848264

Group type: EXPERIMENTAL
Intervention: Kallikrein 600 units daily for 3-6 months
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (30 infertile men)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Kallikrein
Number of subjects: 75
Study: 31051049

Group type: EXPERIMENTAL
Intervention: Medium lithium concentration mineral water (171 µg L‐1)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: High lithium concentration mineral water (1724 µg L‐1)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Low lithium concentration mineral water (1.7 µg L‐1)
Number of subjects: 30
Study: 29217214

Group type: EXPERIMENTAL
Intervention: Good School Toolkit (intervention group)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Waitlisted control group (control group)
Number of subjects: 42
Study: 26190359

Group type: EXPERIMENTAL
Intervention: OrCaSS protocol (intervention group - IG)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Usual care (control group - UCG)
Number of subjects: 18
Study: 24693988

Group type: EXPERIMENTAL
Intervention: Eccentric isokinetic strengthening
Number of subjects: 80

Group type: COMPARATOR
Intervention: Concentric isokinetic strengthening
Number of subjects: 80
Study: 20837967

Group type: EXPERIMENTAL
Intervention: Diabetes mellitus (DM) patients
Number of subjects: 89

Group type: COMPARATOR
Intervention: Control subjects without DM
Number of subjects: 89
Study: 16229689

Group type: EXPERIMENTAL
Intervention: 20 degrees head-up position
Number of subjects: 35
Study: 12018787

Group type: EXPERIMENTAL
Intervention: Attention to one of the two orientations of the elements of a monocular texture
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Texture briefly presented to the opposite eye
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Attention to specific features
Number of subjects: 0
Study: 9630129

Group type: EXPERIMENTAL
Intervention: Family practice
Number of subjects: 509

Group type: COMPARATOR
Intervention: Internal medicine
Number of subjects: 509
Study: 7848544

Group type: EXPERIMENTAL
Intervention: Rifampicin (rifampin)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quinolones
Number of subjects: 0
Study: 3075649

Group type: EXPERIMENTAL
Intervention: Active treatment (chiropractic adjustments of the thoracic spine T1-T5)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 21

Group type: COMPARATOR
Intervention: No treatment control
Number of subjects: 21
Study: 11799430

Group type: EXPERIMENTAL
Intervention: Coronary stenting
Number of subjects: 135

Group type: COMPARATOR
Intervention: Balloon PTCA
Number of subjects: 135
Study: 30617476

Group type: EXPERIMENTAL
Intervention: Simulator-based training until passing a validated test scored by a blinded reviewer
Number of subjects: 20

Group type: COMPARATOR
Intervention: No intervention prior to standard clinical ultrasound training on patients
Number of subjects: 20
Study: 30509293

Group type: EXPERIMENTAL
Intervention: Sensor-augmented pump (SAP) with predictive low glucose suspend and alerts
Number of subjects: 36

Group type: COMPARATOR
Intervention: Insulin pump with flash glucose measurement (FGM) device
Number of subjects: 36
Study: 26433730

Group type: EXPERIMENTAL
Intervention: High-fidelity simulation game with the same cases
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Low-fidelity text-based patient cases
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group working on an e-module
Number of subjects: 61
Study: 24851794

Group type: EXPERIMENTAL
Intervention: Intraoperative platelet-rich plasma (PRP)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (no PRP)
Number of subjects: 40
Study: 22526685

Group type: EXPERIMENTAL
Intervention: Minocycline plus treatment as usual (TAU)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Placebo plus treatment as usual (TAU)
Number of subjects: 144
Study: 21134046

Group type: EXPERIMENTAL
Intervention: BoNTA (botulinum toxin type A free of complexing proteins)
Number of subjects: 21

Group type: COMPARATOR
Intervention: BTXCo (botulinum toxin type A complex)
Number of subjects: 21
Study: 17893629

Group type: EXPERIMENTAL
Intervention: 6% hydroxyethylstarch 130/0.4 (n = 25)
Number of subjects: 50

Group type: COMPARATOR
Intervention: 5% human albumin (n = 25)
Number of subjects: 50
Study: 15261920

Group type: EXPERIMENTAL
Intervention: Emergency coronary angiography with or without rescue PCI
Number of subjects: 307

Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 307
Study: 11791061

Group type: EXPERIMENTAL
Intervention: Stapled anastomosis
Number of subjects: 207

Group type: COMPARATOR
Intervention: Handsewn anastomosis
Number of subjects: 207
Study: 9842818

Group type: COMPARATOR
Intervention: Fentanyl 25 microg (F)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Bupivacaine 2.5 mg (B)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Fentanyl 25 microg + Bupivacaine 2.5 mg (F + B)
Number of subjects: 65